KIT and gastrointestinal stromal tumor: Previously, KIT signaling after TKI treatment in GIST-T1/816 cells harboring KIT exon 11 and 17 (D816E) mutations and GIST-T1/670 harboring KIT exon 11 and 14 (T670I) mutations were reported [22].